Literature DB >> 8450426

Kinetic analysis of glycyrrhetic acid, an active metabolite of glycyrrhizin, in rats: role of enterohepatic circulation.

J Kawakami1, Y Yamamura, T Santa, H Kotaki, K Uchino, Y Sawada, T Iga.   

Abstract

The role of enterohepatic circulation of glycyrrhetic acid (GA) in rats was determined by kinetic analysis of GA. The concentrations of GA in the plasma of the control rat (without bile duct cannulation) during the first 5 h after intravenous (iv) administration of GA (2, 5, 10, and 20 mg/kg) were similar to those in the bile duct-cannulated rat at each dose. No significant difference was observed in the values of the terminal half-life, the total body clearance, the distribution volume at steady state, the area under the curve of concentration in plasma versus time, and the mean residence time in each dose between both groups. When GA (2, 5, 10, and 20 mg/kg) was administered i.v. to the bile duct-cannulated rat, excretion of unchanged GA in bile was < 1% of each dose, that of the acid-hydrolyzed products was 14-16%, and that of GA-3-O-glucuronide was only 1-2%. In the control rat, a secondary peak of GA concentration was observed 12 h after i.v. administration of GA (20 mg/kg). The enterohepatic circulation of GA was confirmed by the linked-rat method in which bile of the donor rat after i.v. administration of GA (20 mg/kg) was allowed to flow directly into the duodenum of the recipient rat. GA was found in the plasma of the recipient rat after 6 h, and its concentration reached the maximum (approximately 0.5 microgram/mL) 8-12 h after dosing the donor rat.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8450426     DOI: 10.1002/jps.2600820317

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  6 in total

1.  Pharmacokinetics of vitexin-4″-O-glucoside in rats after intravenous application.

Authors:  Xi Xiang Ying; Fei Wang; Zhong Zhe Cheng; Wen Jie Zhang; Hai Bo Li; Yang Du; Xun Liu; Si Yuan Wang; Ting Guo Kang
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2011-11-06       Impact factor: 2.441

2.  Evaluation of the safety and efficacy of Glycyrrhiza uralensis root extracts produced using artificial hydroponic-field hybrid cultivation systems II: comparison of serum concentration of glycyrrhetinic acid serum concentration in mice.

Authors:  Mitsuhiko Nose; Kazuma Yamanaka; Shinsuke Hisaka; Takayuki Inui; Noriaki Kawano; Shigeki Hayashi; Atsuyuki Hishida; Hiroyuki Fuchino; Nobuo Kawahara; Kayo Yoshimatsu
Journal:  J Nat Med       Date:  2019-04-26       Impact factor: 2.343

3.  A semi-physiologically based pharmacokinetic pharmacodynamic model for glycyrrhizin-induced pseudoaldosteronism and prediction of the dose limit causing hypokalemia in a virtual elderly population.

Authors:  Ruijuan Xu; Xiaoquan Liu; Jin Yang
Journal:  PLoS One       Date:  2014-12-02       Impact factor: 3.240

4.  Blocking autophagy enhances the apoptotic effect of 18β-glycyrrhetinic acid on human sarcoma cells via endoplasmic reticulum stress and JNK activation.

Authors:  Shuying Shen; Menglu Zhou; Kangmao Huang; Yizheng Wu; Yan Ma; Jiying Wang; Jianjun Ma; Shunwu Fan
Journal:  Cell Death Dis       Date:  2017-09-21       Impact factor: 8.469

5.  Physiology-Based Pharmacokinetic Study on 18β-Glycyrrhetic Acid Mono-Glucuronide (GAMG) Prior to Glycyrrhizin in Rats.

Authors:  Mengxin Cao; Jiawei Zuo; Jian-Guo Yang; Chenyao Wu; Yongan Yang; Wenjian Tang; Lili Zhu
Journal:  Molecules       Date:  2022-07-21       Impact factor: 4.927

6.  Glycyrrhetinic acid induces cytoprotective autophagy via the inositol-requiring enzyme 1α-c-Jun N-terminal kinase cascade in non-small cell lung cancer cells.

Authors:  Zheng-Hai Tang; Le-Le Zhang; Ting Li; Jia-Hong Lu; Dik-Lung Ma; Chung-Hang Leung; Xiu-Ping Chen; Hu-Lin Jiang; Yi-Tao Wang; Jin-Jian Lu
Journal:  Oncotarget       Date:  2015-12-22
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.